When does Edwards Lifesciences report earnings?

Edwards Lifesciences Corporation · end-of-day data as of Nov 13, 2026

Edwards Lifesciences

EW · $61.61B

$107.15+1.3%

Nov 13, 2026 · close

▲ 5

ConsensusBuy · 33
MAs4 of 4
MA20×50Golden 10d ago
MACD1.23
Sector▲ +15.9%

Neutral

Earnings in88d
P/E60.5x
Support-11.9%
Off 52w high-0.5%
Volume0.8x
Bollingerupper half
News0.00
FCF yield+2.3%
Trendsideways
52w range$75–$108
ATR+2.7%
Off ATH-18.7%

▼ 5

PT$105.21 -1.8%
P/E vs own+27.5%
P/E vs sector+87.9%
Insiders-$10.89M
RSI80

Updates with the 15-min delayed price. Not a forecast or investment advice.

Edwards Lifesciences EW reports its next earnings on Tuesday, Feb 9, 2027, after the close, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.66 on revenue of $1.71B. Edwards Lifesciences beat the EPS estimate in 7 of its last 8 reports, and the stock moved ±4.0% on average the session after. The last report, on Nov 4, 2026: EPS of $0.80 against $0.74 expected and revenue of $1.72B against $1.68B; the stock rose 1.5% the next session.

The stock around its reports

Last close $107.15 · +60.6% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +10.5% year over year, free cash flow 29.5% of revenue, operating margin -0.8%.

RevenueFree cash flow


Q3 FY2026	Sep 30, 2026	$1.72B	0.53	$507M	78.5%	-0.8%	17.9%
Q2 FY2026	Jun 30, 2026	$1.74B	0.42	$585M	77.6%	29.8%	13.9%
Q1 FY2026	Mar 31, 2026	$1.65B	0.66	-$21.1M	78.2%	31.2%	23.1%
Q4 FY2025	Dec 31, 2025	$1.57B	0.16	$354M	78.3%	23.6%	5.8%
Q3 FY2025	Sep 30, 2025	$1.55B	0.50	$516M	77.9%	27.4%	18.7%
Q2 FY2025	Jun 30, 2025	$1.53B	0.56	$241M	77.6%	28.1%	21.5%
Q1 FY2025	Mar 31, 2025	$1.41B	0.61	$224M	78.7%	27.9%	25.3%
Q4 FY2024	Dec 31, 2024	$1.39B	0.65	-$177M	78.9%	22.6%	27.8%